ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

fluticasone furoate

Also written as “GW685698X”, “FF/UMEC/VI” and “Fluticasone furoate”.

Its studies are mostly in Asthma · Pulmonary Disease, Chronic Obstructive · Rhinitis, Allergic, Perennial · Rhinitis, Allergic, Seasonal · Rhinitis, Allergic, led by 4 companies.

Drug pageFluticasone furoate: every studyAll 105 studies of it, academic ones too, with its approvals, label and forms.
Furthest: phase 4, since Feb 14, 200797 company-led studies, 2 open or runningNext primary completion: Jan 26, 2027 (phase 3)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
GlaxoSmithKline942 open or runningphase 4since Feb 14, 2007Feb 8, 2005Jan 26, 2027phase 3 · NCT05757102
Novartisits history only10 open or runningphase 3since Jan 17, 2011Jan 17, 2011none ahead
ORAits history only10 open or runningphase 4since Feb 24, 2010Feb 24, 2010none ahead
Sandozits history only10 open or runningphase 3since Oct 15, 2025Oct 15, 2025none ahead

Also a collaborator on its studies: Parexel.

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and studies of GlaxoSmithKline only; the figures above count every company.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

Before these, 44 studies since Mar 11, 2010.

  1. Mar 14, 2016Phase 2 study in AsthmaNCT02712047 · 28 enrolled · New Zealand
  2. Mar 24, 2016Phase 4 study in AsthmaNCT02730351 · 75 enrolled · United States, Canada
  3. Jul 15, 2016Phase 1 study in Pulmonary Disease, Chronic ObstructiveNCT02837380 · 16 enrolled · China
  4. Aug 31, 2016Phase 4 study in AsthmaNCT02889809 · 477 enrolled · United States, Argentina, Poland and more
  5. Nov 30, 2017Phase 4 study in AsthmaNCT03363191
  6. Dec 1, 2017Phase 3 study in AsthmaNCT03376932
  7. Feb 2, 2018Phase 4 study in Pulmonary Disease, Chronic ObstructiveNCT03467425 · 3,109 enrolled · Germany, Netherlands, Spain and more
  8. Mar 15, 20183 phase 4 studies in Pulmonary Disease, Chronic ObstructiveNCT03474081, NCT03478696, NCT03478683
  9. May 13, 2019Phase 4 study in Pulmonary Disease, Chronic ObstructiveNCT03949842 · United States
  10. Jun 2, 2021Phase 3 study in AsthmaNCT04937387 · 359 enrolled · China
  11. Jun 6, 2021Phase 4 study in Pulmonary Disease, Chronic ObstructiveNCT04923347 · 229 enrolled · India
  12. Sep 7, 2022Phase 4 study in Pulmonary Disease, Chronic ObstructiveNCT05535972 · 463 enrolled · China
  13. Feb 24, 2023Phase 3 study in AsthmaNCT05757102 · 138 enrolled · United States, Argentina, Australia and more
  14. Apr 15, 2024Phase 4 study in AsthmaNCT06372496 · 1,358 enrolled · United States, Argentina, Australia and more

Ahead

  1. Jan 26, 2027Primary completion: phase 3 study in AsthmaNCT05757102

TargetBeta

NR3C1 →read by rule
“Glucocorticoid receptor agonist”ChEMBL 37, by rule

Other programs on NR3C1

ProgramCompanyFurthest phaseStudies
DexamethasoneruleAbbViephase 4174
BudesonideruleAstraZenecaphase 4167
PrednisoneruleJohnson & Johnsonphase 465
BeclomethasoneruleChiesi Farmaceuticiphase 446
PrednisoloneruleSanofiphase 434
betamethasone dipropionateruleLEO Pharmaphase 427
MethylprednisolonerulePfizerphase 423
dexamethasone phosphateruleeyegate-pharmaceuticals-incphase 421
BetamethasoneruleLEO Pharmaphase 49
Triamcinoloneruleresearch-insight-llcphase 45
relacorilantruleCorcept Therapeuticsphase 322
Triamcinolone Acetonideruleclearside-biomedical-incphase 320

Studies

The newest 60 of 94 GlaxoSmithKline leads. Each opens its study page. Every study on its drug page →

StudyPhaseStatusPrimary completionSize
NCT06372496Asthma · United States, Argentina, Australia and more4Active, not recruitingJul 28, 20251,358
NCT05757102Asthma · United States, Argentina, Australia and more3Active, not recruitingJan 26, 2027138
NCT05535972Pulmonary Disease, Chronic Obstructive · China4CompletedSep 25, 2023463
NCT04923347Pulmonary Disease, Chronic Obstructive · India4CompletedMar 14, 2024229
NCT04937387Asthma · China3CompletedAug 5, 2024359
NCT03949842Pulmonary Disease, Chronic Obstructive · United States4WithdrawnNov 30, 20220
NCT03478696Pulmonary Disease, Chronic Obstructive · United States, Czechia, Germany4CompletedMar 18, 2019732
NCT03478683Pulmonary Disease, Chronic Obstructive · United States, Czechia, Germany and more4CompletedMar 14, 2019729
NCT03474081Pulmonary Disease, Chronic Obstructive · United States, Poland, Russian Federation4CompletedJul 17, 2019800
NCT03467425Pulmonary Disease, Chronic Obstructive · Germany, Netherlands, Spain and more4CompletedOct 10, 20193,109
NCT03376932Asthma3WithdrawnFeb 3, 20210
NCT03363191Asthma4WithdrawnMay 29, 20190
NCT02889809Asthma · United States, Argentina, Poland and more4CompletedApr 9, 2021477
NCT02837380Pulmonary Disease, Chronic Obstructive · China1CompletedNov 201616
NCT02730351Asthma · United States, Canada4CompletedFeb 3, 201775
NCT02712047Asthma · New Zealand2CompletedFeb 21, 201728
NCT02666287Pulmonary Disease, Chronic Obstructive · United Kingdom1CompletedJun 3, 201648
NCT02573870Pulmonary Disease, Chronic Obstructive · United States2CompletedJul 5, 201663
NCT02502734Asthma · Denmark3CompletedDec 21, 201560
NCT02483975Asthma · United States, South Africa3CompletedJun 20, 2016111
NCT02446418Asthma · France, Germany3CompletedJul 20, 2017423
NCT02164513Pulmonary Disease, Chronic Obstructive · United States, Argentina, Australia and more3CompletedJul 17, 201710,355
NCT02105974Pulmonary Disease, Chronic Obstructive · United States, Bulgaria, Germany and more3CompletedJul 8, 20151,621
NCT02094937Asthma · Japan3CompletedAug 28, 2015430
NCT02064504Pulmonary Disease, Chronic Obstructive · Australia1CompletedMay 20, 201448
NCT01962467Rhinitis · Australia1CompletedFeb 27, 201430
NCT01957150Pulmonary Disease, Chronic Obstructive · United States, Canada, Germany and more4CompletedMar 26, 2018283
NCT01808339Asthma · Australia2CompletedMar 201428
NCT01691547Pulmonary Disease, Chronic Obstructive · United States1CompletedMar 8, 201344
NCT01686633Asthma · United States, Argentina, Chile and more3CompletedOct 1, 20131,040
NCT01691885Pulmonary Disease, Chronic Obstructive · United Kingdom3CompletedJul 201445
NCT01630135Rhinitis, Allergic, Perennial · Japan3CompletedAug 2012261
NCT01627327Pulmonary Disease, Chronic Obstructive · United States, Canada, Czechia and more3CompletedDec 1, 2012623
NCT01622231Rhinitis · Japan3CompletedNov 201261
NCT01563029Asthma · United States, Bulgaria, Georgia and more2CompletedSep 24, 2014597
NCT01498679Asthma · China, Korea, Republic of, Philippines3CompletedJul 2013311
NCT01498653Asthma · China, Korea, Republic of, Philippines3CompletedFeb 2013313
NCT01499446Asthma · Brazil, Bulgaria, Chile and more2CompletedMar 2004669
NCT01485445Asthma · Germany1CompletedMar 12, 201230
NCT01436110Asthma · United States, Mexico, Netherlands and more3CompletedSep 2012351
NCT01436071Asthma · United States, Mexico, Peru and more3CompletedJun 2012248
NCT01435902Asthma3WithdrawnAug 20120
NCT01431950Asthma · United States, Argentina, Chile and more3CompletedOct 2012238
NCT01395888Pulmonary Disease, Chronic Obstructive · Argentina, France, Germany and more3CompletedAug 1, 2012260
NCT01342913Pulmonary Disease, Chronic Obstructive · Belgium, France, Germany and more3CompletedOct 1, 2011528
NCT01323634Pulmonary Disease, Chronic Obstructive · United States, Czechia, Germany and more3CompletedDec 14, 2011519
NCT01323621Pulmonary Disease, Chronic Obstructive · United States, Germany, Italy and more3CompletedJan 1, 2012512
NCT01313676Pulmonary Disease, Chronic Obstructive · United States, Argentina, Australia and more3CompletedJul 15, 201516,568
NCT01244984Asthma · Japan3CompletedJan 2012243
NCT01332292Asthma · United States2CompletedJan 201127
NCT01231464Rhinitis, Allergic, Perennial · China3CompletedMay 2010365
NCT01213849Asthma · United Kingdom1CompletedNov 25, 201024
NCT01165138Asthma · United States, Germany, Japan and more3CompletedOct 1, 2011612
NCT01159912Asthma · United States, Belgium, Germany and more3CompletedJan 1, 2012350
NCT01299558Asthma · Australia1CompletedJul 15, 201016
NCT01147848Asthma · United States, Argentina, Chile and more3CompletedJul 2011810
NCT01134042Asthma · United States, Germany, Japan and more3CompletedOct 2011587
NCT01128595Asthma · Australia, New Zealand, Sweden2CompletedMay 201127
NCT01128569Asthma · Germany, New Zealand, United Kingdom2CompletedOct 201052
NCT01086384Asthma · United States, Argentina, Australia and more3CompletedSep 1, 20112,020

How it is read

Names in the registry

  • “GW685698X”, 16 entries
  • “FF/UMEC/VI”, 9 entries
  • “Fluticasone furoate”, 8 entries
  • “FF”, 6 entries
  • “Fluticasone Furoate”, 5 entries

Codes read as this program: GW685698.

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.